Premium
CARDIOLOGY
Author(s) -
Nadia Kilani,
Christelle Haddad,
Henri Lu,
Fahime Ghanbari,
Giulia Domenichini,
Anna-Giulia Pavon,
Georgios Tzimas,
Stéphane Fournier,
Roger Hullin,
Patrizio Pascale,
Eric Eeckhout,
Juerg Schwitter,
Etienne Pruvot,
Judith Bouchardy,
Pierre Monney,
Olivier Muller,
Tobias Rutz
Publication year - 1924
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1924.tb65486.x
Subject(s) - citation , computer science , information retrieval , medicine , library science
In 2020, new guidelines have been published by the European Society of Cardiology including those on non-ST-segment elevation acute coronary syndromes, atrial fibrillation and adult congenital heart disease. Regarding interventional cardiology, POPular TAVI opens the possibility of anti-platelet monotherapy after transcutaneous aortic valve replacement. EMPEROR-Reduced confirms the importance of SGLT2 inhibitors in the treatment of heart failure with reduced ejection fraction. Within the field of imaging, stress MRI has now become the first-line technique for the screening of coronary artery disease, demonstrating an excellent cost-benefit ratio. Finally, renin-angiotensin-aldosterone inhibitors do not appear to increase the risk of an infection by COVID-19.